CareDx (CDNA)
(Real Time Quote from BATS)
$18.01 USD
-0.56 (-3.02%)
Updated Jul 17, 2024 01:16 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
CareDx (CDNA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$17.75 | $22.00 | $14.00 | -4.42% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for CareDx comes to $17.75. The forecasts range from a low of $14.00 to a high of $22.00. The average price target represents a decline of 4.42% from the last closing price of $18.57.
Analyst Price Targets (4 )
Broker Rating
CareDx currently has an average brokerage recommendation (ABR) of 1.86 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.86 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, four are Strong Buy, representing 57.14% of all recommendations. A month ago, Strong Buy represented 57.14%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/CDNA.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 3 |
Buy | 0 | 0 | 0 | 0 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.86 | 1.86 | 1.86 | 1.86 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/15/2024 | H.C. Wainwright & Co. | Yi Chen | Hold | Hold |
5/13/2024 | Goldman Sachs | Matthew Sykes | Strong Buy | Strong Buy |
5/13/2024 | Raymond James | Andrew Cooper | Moderate Buy | Hold |
5/1/2024 | Craig-Hallum | William B Bonello | Not Available | Strong Buy |
4/17/2024 | Stephens | Mason Carrico | Strong Buy | Strong Buy |
1/7/2024 | BTIG | Mark Massaro | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.86 |
ABR (Last week) | 1.86 |
# of Recs in ABR | 7 |
Average Target Price | $17.75 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 78 of 252 |
Current Quarter EPS Est: | -0.13 |